Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
Clinical Cancer Research(2022)
Key words
Fibroblast Growth Factor,Neurofibromatosis,Gliomas,Chromatin Remodeling
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined